QA: Bioverativ Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001681689_2018_Bioverativ_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001681689, Bioverativ Inc

  xvar xval
0 AssetsCurrent 778,300,000
1 IntangibleAssetsNetIncludingGoodwill 806,600,000
2 PropertyPlantAndEquipmentNet 24,000,000
3 remainder_Assets 9,400,000
4 LiabilitiesCurrent 390,100,000
5 LiabilitiesNoncurrent 92,500,000
6 remainder_Liabilities 238,100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 217,100,000
9 ResearchAndDevelopmentExpense 224,600,000
10 remainder_Expenses 375,900,000
11 remainder_Revenues 1,168,500,000
12 remainder_NetIncome 4,700,000
13 remainder_ComprehensiveNetIncome -1,800,000
  yvar yval
0 Assets 1,618,300,000
1 Liabilities 720,700,000
2 Expenses 817,600,000
3 Revenues 1,168,500,000
4 StockholdersEquity 897,600,000
5 NetIncome 355,600,000
6 ComprehensiveNetIncome 354,700,000
7 BaseVar 2,165,800,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.98
9 EconomicCapitalRatio 3.01

Edgar->Model Mapping

Feature Distribution